Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

A Form 4 filing reveals Agenus Inc. CEO Garo H. Armen received 4,777 shares of common stock at $3.12 per share as part of his salary compensation.

Summary

• Garo H. Armen, CEO of Agenus Inc., received 4,777 shares of Agenus common stock on January 10, 2025, as part of his salary.
• This compensation was in lieu of a cash payment and was approved by the Agenus Inc. Compensation Committee.
• The stock was issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive and is fully vested upon issuance.
• The price of the stock was $3.12 per share, which was the closing price of Agenus common stock on January 10, 2025.
• Following the transaction, Armen directly owns 129,148 shares.
• Armen also indirectly owns 31,298 shares through his IRA accounts and 28,950 shares as trustee and investment authority for the Garo Armen 2020 2 Year AG GRAT and as a general partner in Pixie Partners.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of executive compensation. The CEO taking stock in lieu of cash could be seen as a positive signal, but it's not a major event.

Positives

• The CEO's decision to take salary in stock demonstrates confidence in the company's future.
• The stock was issued under the 2019 Equity Incentive Plan and is fully vested.

Industry Context

Stock-based compensation is a common practice in the biotech industry, particularly for executive roles, to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Many biotech companies use stock options and restricted stock units (RSUs) as part of their executive compensation packages.
• Companies like Amgen, Gilead, and Regeneron also utilize stock-based compensation to attract and retain top talent.
• The specific amount and structure of stock-based compensation vary depending on the company's size, stage of development, and financial performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with theirs.
• Employees may view the CEO taking stock as a sign of confidence in the company.

Key Dates